Dosimetry and outcomes in patients receiving radiotherapy for synchronous bilateral breast cancers.

Abstract

BACKGROUND:

Synchronous bilateral breast cancer (SBBC) is rare and there is little evidence describing organs at risk (OAR) and limits to the heart and lungs caused by radiotherapy (RT). Quantifying mean heart dose (MHD) and mean lung dose (MLD) from RT in this patient cohort may lead to better understanding of doses to OAR and resultant effects on clinical outcomes. The primary objective was to assess median MHD and MLD in SBBC, while secondary aims included analyses of 1) factors associated with MHD and MLD, 2) V5 and V20 values and 3) factors associated with clinical outcomes.

METHODS:

Patients planned for adjuvant bilateral whole breast/chest wall (WB) RT from a single institution treated in 2011-2018 were included. Median MHD and MLD (Gy) were stratified by hypofractionated (42.56 Gy/16 fractions, HFRT) and conventional fractionation (50 Gy/ 25 fractions, CFRT) and summarized separately based on the following treatments: 1) locoregional RT, WB tangential RT either 2) no boost 3) sequential boost or 4) simultaneous integrated boost. MHD, MLD, lung V5 and V20 values, and demographics were collected. Linear regression analyses identified factors associated with MHD and MLD and factors associated with clinical outcomes.

RESULTS:

A total of 88 patients were included. The median MHD for HFRT and CFRT was 1.99 Gy and 2.94 Gy, respectively. The median MLD for HFRT and CFRT was 6.00 Gy and 10.08 Gy, respectively. MHD and MLD were significantly associated with the occurrence of a cardiac or pulmonary event post-radiation. Patients who had a mastectomy or tumoral muscle involvement were more likely to develop a local recurrence, metastasis or new primary while patients who had a lumpectomy or tumor with a positive estrogen receptor status were less likely to experience these events.

CONCLUSIONS:

Further investigation should be conducted to identify SBBC RT techniques that mitigate dose to OARs to improve clinical outcomes in bilateral breast patients.

• Authors: Erin McKenzie, Yasmeen Razvi, Sandi Bosnic, Matt Wronski, Liying Zhang, Irene Karam, Elysia Donovan, Lauren Milton, Tara Behroozian, Leah Drost, Caitlin Yee, Gina Wong, Emily Lam, Edward Chow
• Journal: Journal of medical imaging and radiation sciences (J Med Imaging Radiat Sci) Vol. 52 Issue 4 Pg. 527-543 (12 2021) ISSN: 1876-7982 [Electronic] United States
• PMID: 34580051 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2021. Published by Elsevier Inc.

Topics

• Breast Neoplasms (radiotherapy)
• Female
• Heart
• Humans
• Mastectomy
• Organs at Risk
• Radiometry